Navigation Links
Synthetic Biology Importance in the 21st Century
Date:12/17/2008

Five free iPods to those who test their knowledge at www.synbioproject.org

WASHINGTON, Dec. 17 /PRNewswire-USNewswire/ -- Among the 75 people Esquire magazine recently chose as the most influential in the 21st century are three researchers in an emerging discipline that combines science and engineering in order to design and build novel biological functions and systems -- otherwise known as synthetic biology.

The promise of this burgeoning scientific field lies in the potential to apply engineering principles to the fundamental components of biology. This includes the design and construction of new biological parts, devices, and systems (e.g., tumor-seeking microbes for cancer treatment), as well as the re-design of existing, natural biological systems for useful purposes (e.g., plants making energy). To test your knowledge of synthetic biology and potentially win a free iPod, visit www.synbioproject.org/quiz.

In response to this emerging field, the Synthetic Biology Project is being launched to identify gaps in our knowledge of the potential risks of the field, explore public perceptions towards it, and examine governance options that will both ensure public safety and facilitate innovation.

"Humans have been altering the genetic code of plants and animals for millennia, by selectively breeding individuals with desirable features. But more recent advances have enabled scientists to make new sequences of DNA from scratch. By combining these advances with the principles of modern engineering, scientists can now use computers and laboratory chemicals to design organisms that do new things -- like produce biofuels or excrete the precursors of medical drugs," says David Rejeski, the director of the Project.

But just how much about this field is covered in the media? And while these scientists featured in Esquire -- Drew Endy, Jay Keasling and Craig Venter -- may hold the keys to improved medial treatments and cleaner fuels, are there adequate controls and security measures to limit potential risks? The development of www.synbioproject.org marks an effort to answer those questions.

To provide a snapshot of the work to come, the Synthetic Biology Project announces the release of the landmark paper Trends in American and European Press Coverage of Synthetic Biology, which examines coverage of the field in recent years, as well as a quiz that tests your knowledge of synthetic biology.

About Synthetic Biology

Synthetic biology is a maturing scientific discipline that combines science and engineering in order to design and build novel biological functions and systems. This includes the design and construction of new biological parts, devices, and systems, as well as the re-design of existing, natural biological systems for useful purposes.

The Synthetic Biology Project is an initiative launched in 2008 by the Woodrow Wilson International Center for Scholars with the support of the Alfred P. Sloan Foundation. The Synthetic Biology Project provides independent, rigorous analysis that can inform critical decisions affecting the research, commercialization and use of synthetic biology. Its objective is to help ensure that, as synthetic biology moves forward, possible risks are minimized and benefits maximized.

In collaboration with researchers, governments, industries, non-governmental organizations, policymakers and others, the Project will work to identify gaps in our knowledge of the potential risks of synthetic biology, explore public perceptions towards the field, and examine governance options that will both ensure public safety and facilitate innovation.

To learn more about the Project, log on to www.synbioproject.org.

    Contact: Colin Finan
    Phone: (202) 691-4321 (work)
    (202) 841-5605 (cell)
    colin.finan@wilsoncenter.org


'/>"/>
SOURCE Synthetic Biology Project
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. RNAi Helps Illuminate the Inner Workings of the Cell Cycle: Synthetic RNAissance™ Genes Created by DNA2.0 Enable Key Research
2. The MathWorks Sponsors iGEM Competition for Synthetic Biology at MIT : MATLAB and SimBiology Help Accelerate Design of Synthetic Biological Systems
3. WuXi PharmaTech Promotes Dr. Rujian Ma to VP of Synthetic Chemistry
4. ES Vascular Receives CE Mark for its First Aortic Stapler for End-to-End Anastomosis Between Synthetic Grafts and Aorta During Open Repair of Aortic Aneurysmal and Occlusive Disease
5. Venter Institute Scientists Create First Synthetic Bacterial Genome
6. FDA Approves IXEMPRA(TM) (ixabepilone), a Semi-Synthetic Analog of Epothilone B, for the Treatment of Advanced Breast Cancer
7. CODA Genomics Announces Issuance of Optimized Synthetic Gene Production Patent
8. Laboratory Customers Name bioMerieux Top Of Class for Microbiology
9. Tips from the journals of the American Society for Microbiology
10. Dynamic Signs Asset Acquisition Deal With Cannex and Brings Onboard Leading Medical Cannabis Research Scientist Dr. Robert Melamede, Former Chairman of the Biology Department, University of Colorado
11. Swedish Neuroscience Institute and Institute for Systems Biology in Seattle Form Alliance to Learn More about Brain Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... (NASDAQ: VWR), the leading global independent provider of product and ... financial results for the fourth quarter and full year ended ... 4Q16 record quarterly net sales of $1.13 billion, up 1.6% ... 4Q16 EMEA-APAC segment net sales increased 0.4%, ... sales increased 2.5%, or down 0.9% on an organic basis, ...
(Date:2/23/2017)... SAN RAFAEL, Calif., Feb. 23, 2017 ... of U.S. dollars, except per share data, unaudited)Three Months ... ChangeTotal BioMarin Revenue $ ...     22832%$ 1,117$   89026%Aldurazyme Net Product Revenue ... 906538%34823946%Naglazyme Net Product Revenue  ...
(Date:2/23/2017)... Calif. , Feb. 23, 2017  MIODx ... license for two key immunotherapy technologies from the ... technology provides a method to monitor a patient ... as PD-L1 and CTLA-4.  The second license extends ... a patient is likely to have an immune-related ...
(Date:2/23/2017)... , Feb. 23, 2017  Imanis Life ... product line of oncolytic vaccinia viruses for virotherapy ... as part of Genelux,s proprietary, vaccinia virus-based technology ... excited to enter into a partnership with Genelux ... oncolytic vaccinia viruses for use in research," said ...
Breaking Biology Technology:
(Date:2/24/2017)... -- EyeLock LLC, a leader of iris-based identity authentication ... solution on the latest Qualcomm® Snapdragon™ 835 mobile ... Congress 2017 (February 27 – March 2, ... Stand 3E10. The Snapdragon 835 ... combination of hardware, software and biometrics technologies ...
(Date:2/21/2017)... , February 21, 2017 Der ... US-Dollar wachsen. Nach einem Gespräch mit mehr als 50 Vertretern ... Hindernisse zu überwinden gilt, um diese Prognose zu realisieren. ... ... die Mobilisierung der finanziellen Mittel für die Biobank, die ...
(Date:2/13/2017)... , Feb. 13, 2017  RSA Conference -- ... platform that is designed to enhance fraud detection ... release in the RSA Fraud & Risk Intelligence ... organizations to leverage additional insights from internal and ... to better protect their customers from targeted cybercrime ...
Breaking Biology News(10 mins):